Evidence map›Paper›PMID 38503523›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2023

[Synergistic effect of azacitidine with homoharringtonine by activating the c-MYC/DDIT3/PUMA axis in acute myeloid leukemia].

J Li, Y Q Huang, J Zi, C H Song, Z Ge

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

J LiDepartment of Hematology, Zhongda Hospital, School of Medicine, Southeast University, Institute of Hematology Southeast University, Nanjing 210009, China.
Y Q HuangDepartment of Hematology, Zhongda Hospital, School of Medicine, Southeast University, Institute of Hematology Southeast University, Nanjing 210009, China.
J ZiDepartment of Hematology, Zhongda Hospital, School of Medicine, Southeast University, Institute of Hematology Southeast University, Nanjing 210009, China.
C H SongPennysvinia State University, College of Medicine and Hershey Medical Center, Hershey, PA 17033, USA Division of Hematology, The Ohio State University Wexner Medical Center and The James Cancer Hospital, Columbus, OH 43210, USA.
Z GeDepartment of Hematology, Zhongda Hospital, School of Medicine, Southeast University, Institute of Hematology Southeast University, Nanjing 210009, China.
Zhongda Hospital Southeast University · CN

Funding

Jiangsu Province Medical Key Discipline (Laboratory) Cultivation Unit JSDW202212Medical Research Key Projects - Jiangsu Commission of Health ZD2021003The Postgraduate Research & Practice Innovation Program of Jiangsu Province KYCX22_0296
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AzacitidineLeukemia, Myeloid, AcuteApoptosisApoptosis Regulatory ProteinsCell Line, TumorHomoharringtonineHumansTranscription Factor CHOPApoptosis Regulatory ProteinsAzacitidineDDIT3 protein, humanHomoharringtonineTranscription Factor CHOPAzacitidineHomoharringtonineLeukemia, myeloid, acuteSynergistic effect

Identifiers

PMID38503523
PMCPMC10834876
OpenAlexW4394741195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.